1h Free Analyst Time
The specialty pharmaceuticals market is forecasted to grow by USD 503.1 billion during 2024-2029, accelerating at a CAGR of 14.8% during the forecast period. The report on the specialty pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for research and development due to government healthcare expenditure, need for cost-cutting in specialty pharmaceutical discovery and development, and initiatives by government and various non-profit organizations to spread awareness of complex diseases and their prevention.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The specialty pharmaceuticals market is segmented as below:
By Application
- Oncology
- Multiple sclerosis
- Inflammatory conditions
- Infectious diseases
- Others
By Distribution Channel
- Offline
- Online
By Route Of Administration
- Inhalation
- Injectable
- Oral
- Topical
- Transdermal
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the specialty pharmaceuticals market covers the following areas:
- Specialty Pharmaceuticals Market sizing
- Specialty Pharmaceuticals Market forecast
- Specialty Pharmaceuticals Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by Distribution Channel
10 Market Segmentation by Route of Administration
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global specialty pharmaceuticals market: AbbVie Inc., Amgen Inc., Bristol Myers Squibb Co., CVS Health Corp., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Humana Inc., Hyphens Pharma Pte Ltd., Johnson and Johnson Services Inc., McKesson Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., The Cigna Group, United Health Group Inc., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing geriatric population."
According to the report, one of the major drivers for this market is the increasing demand for research and development due to government healthcare expenditure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Bristol Myers Squibb Co.
- CVS Health Corp.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Humana Inc.
- Hyphens Pharma Pte Ltd.
- Johnson and Johnson Services Inc.
- McKesson Corp.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Supernus Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- United Health Group Inc.
- Viatris Inc.
